Oncology & Cancer

Tailoring treatment for triple-negative breast cancer

Immunotherapies have revolutionized treatment for people with a variety of cancers. But when given to those with triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, less than 20% respond.

Medical research

New cancer treatment not as toxic as others

A QIMR Berghofer study has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells.

Neuroscience

Study explores blood-brain barrier leakage in CNS infections

A new study published in the journal mBio shines light on the breakdown of the blood-brain barrier (BBB) that occurs during many infections of the central nervous system. The findings implicate interferon gamma, a major cytokine ...

Diseases, Conditions, Syndromes

Guidelines updated for TB screening, treatment in health care workers

(HealthDay)—Guidelines have been updated for screening and treatment for tuberculosis (TB) infection among health care personnel, according to research published in the May 17 issue of the U.S. Centers for Disease Control ...

Immunology

Pediatric health researchers offer insights for RSV vaccine

In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough. However, it is the second leading cause of death in infants. In fact, nearly 40 percent of ...

Neuroscience

Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

page 9 from 27